Consensus ‘Interferon therapy for patients with influenza, SARS and COVID19’

Author:

Yushchuk N. D.1ORCID,Maev I. V.1ORCID,Vertkin A. L.1ORCID

Affiliation:

1. Moscow State University of Medicine and Dentistry n.a. A. I. Evdokimov

Abstract

According to the who, the share of acute respiratory viral infections (амма? and influenza) accounts for about 90–95% of all infectious diseases; in russia, influenza and arvi take up to 40% of the total duration of official disability, which determines the significance of this pathology. At the same time, the primary contact of the overwhelming majority of patients with suspected arvi and influenza occurs with a therapist or general practitioner of polyclinics. The proposed consensus of experts is intended to systematize the known approaches to the diagnosis, treatment and secondary prevention of influenza, acute respiratory viral infections and community-acquired pneumonia for their use at outpatient clinics. The schemes of using interferon therapy for arvi and influenza are considered in detail.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference17 articles.

1. ВОЗ. Информационный бюллетень. Грипп. Ноябрь 2019 г. WHO. Newsletter. Flu. November 2019

2. On the state of sanitary and epidemiological well-being of the population in the Russian Federation in 2016: state report. Federal Service for Supervision of Consumer Rights Protection and Human Welfare. Moscow: 2017.220 p.

3. Influenza and acute respiratory viral infections: modern rational etiotropic and pathogenetic therapy. Algorithms for providing medical care to patients: method. recommendations. Authors-compilers: Nikiforov V.V. et al. M .: Spetskniga. 2018, 20 p.

4. Influenza in adults. Clinical guidelines of the National Scientific Society of Infectious Diseases, 2014.105 p.

5. Smetanina S. V., Nikiforov V. V., Kolobukhina L. V. New coronavirus infection (COVID 19): etiology, epidemiology, clinical presentation, diagnosis, treatment and prevention. Moscow: Moscow City Health Department, 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3